Cabaletta Bio is trading at $2.68 (+5.10%) in pre-market amid broader risk-on sentiment.

  • No new company-specific announcement dated September 21, 2026 was identified; the latest listed updates concern investor conferences and second-quarter results.
  • Major U.S. indices are up more than 0.5% in pre-market, likely supporting the move.
  • Recent warrant-exercise proceeds and conference appearances are earlier developments, not confirmed same-day catalysts.